Navigation Links
MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Date:6/4/2008

MOUNTAIN VIEW, Calif., June 4 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Tuesday, June 10, 2008, at 4:00 pm (PT) in Dana Point, California.

A live webcast of the presentation will be available on the Investor Relations section of MAP Pharmaceuticals' website at http://www.mappharma.com. A replay will also be available within 24 hours for seven days following the presentation.

About MAP Pharmaceuticals, Inc.

MAP Pharmaceuticals develops and plans to commercialize new therapies for children and adults who suffer from chronic conditions that it believes are not adequately treated by currently available medicines. The Company applies its proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. MAP Pharmaceuticals has two drug candidates, Unit Dose Budesonide and MAP0004, in late stage development for the potential treatment of pediatric asthma and migraine respectively. MAP Pharmaceuticals' pipeline also includes a drug candidate in early clinical development for the treatment of asthma and chronic obstructive pulmonary disease.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
2. Antipodean Pharmaceuticals Announces FDA Acceptance of IND for MitoQ(R)
3. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
4. Vion Pharmaceuticals Announces Presentation of Data from Phase III Trial of Cloretazine(R) (VNP40101M) and Cytarabine in Relapsed Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting
5. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
6. Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
7. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
8. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
9. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
10. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
11. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Minneapolis, Minnesota (PRWEB) , ... July 29, 2015 , ... ... The Sofia Fund, which invests in women-led, growth companies and is led by a ... Investors have responded positively, and voted with their dollars to be a part ...
(Date:7/29/2015)... , ... July 29, 2015 , ... CanAm Enterprises, LLC ... USCIS over the past month! I-829 approvals have been granted to investors in four ... Angeles, the Kimpton Lafayette Hotel project in Philadelphia, and the Valley Forge Convention Center ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by ... in March, Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine ... with demonstrated financial need. , “We are thrilled for this opportunity to offer ...
(Date:7/29/2015)... ... ... Employee Fiduciary, LLC announces the launch of its new, online Financial Advisor ... administered, years in business, and credentials of all Employee Fiduciary financial advisor partners ... Fiduciary. A search can be done by zip code so a plan sponsor can ...
(Date:7/29/2015)... ... 29, 2015 , ... TransFlip is an all new dynamic transition pack for ... FCPX, these transitions are easy to apply and modify for any skill-level user. TransFlip ... 60 preset styles, kinetic flipping panel animations are just a few clicks away. , ...
Breaking Medicine News(10 mins):Health News:Sofia Fund Surpasses Investor Goals 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 2Health News:More Than 60 New I-829 Approvals in Less Than 30 days for CanAm 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2
... ... effective in aiding weight loss. Users say it helps them lose up to 40 ... ... of "super chocolate" has been fast increasing popularity among international models and athletes as ...
... (embargo: 6 May, 16:45 CEST) , J. Hicks, USA, ... from very small samples , Researchers have developed a powerful ... The breakthrough allows them to study in fine detail the ... receptor status of HER2+ breast cancer correlates with response to ...
... of Pediatrics, Global Health and Epidemiology & Biostatistics ... has been selected by the J. William Fulbright ... Fulbright Scholarship. Beginning in August 2010, Dr. Mandalakas ... in collaboration with Stellenbosch University to study the ...
... ... ... CosmoCom the global leader in Contact Center Consolidation 2.0, announced that its healthcare contact ... (LISA). Presented by the Long Island Software and Technology Network (LISTnet), the LISA recognizes ...
... ... ... for the Skinny on Willpower! The publishing industry is in the midst of a revolutionary change, ... The Skinny On series. The series, recent hit, The Skinny On Willpower , addresses ...
... Urns.com Offers New Biodegradable Urns ... More Give People The Option To Have More A Eco-Friendly Funeral. , ... Goleta, CA (PRWEB) May 6, 2010 –- When a loved one ... where those left behind need to consider not only the wishes of the deceased, but also ...
Cached Medicine News:Health News:Super Fat-Melting Chocolate Recipe Revealed 2Health News:Super Fat-Melting Chocolate Recipe Revealed 3Health News:IMPAKT Breast Cancer Conference press program 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 2Health News:CWRU global TB expert receives prestigious Fulbright Scholar Award 3Health News:CosmoCom Wins Software Award for CosmoHealth 2Health News:CosmoCom Wins Software Award for CosmoHealth 3Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 2Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 3Health News:Readers and Reviewers Rave about 'The Skinny On Willpower' 4Health News:Urns.com Announces Urns As An Eco Friendly Burial Alternative 2
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  ViaCyte, Inc., a ... therapy for the treatment of diabetes in clinical trials, today announced ... called STEP ONE, or S afety, T olerability, and ... One Diabetes.  The new site, which is the first ... of Alberta Hospitals in Edmonton , Alberta.  ...
(Date:7/29/2015)... -- Fifty groups representing 500,000 patients, doctors, and researchers will ... AllTrials campaign in the US. The global campaign calls ... be registered and the results from it reported. ... explains: "Patients want the treatments that are best for ... Unfortunately, we now know that around half of all ...
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ... "Global Wound Care Markets (Twelve Country Analysis: Germany, ... China, India, Brazil, Australia, South Korea)" report ... provides a competitive market summary. The wound care ... offerings and product maturity. Several of the products ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Fixing Your Medicine: AllTrials Campaign Launches in US 2Fixing Your Medicine: AllTrials Campaign Launches in US 3Global Wound Care Markets 2015 2
For vacuum-driven processing of spin columns; Reduced sample handling and accelerated processing; Parallel sample processing using QIAGEN spin columns; Easy cleaning of internal components by simpl...
Inquire...
... The Perfect Single Vac ... one 96-well plate in 30 ... with an "open/closed" switch and ... for easy operation. contains vacuum ...
... has been designed for use with Bioneer's ... can handle 96 samples (Plasmid DNA, Genomic ... and purification. While conventional kits use centrifugal ... BioVac 96 Vacuum Manifold uses vacuum pressure ...
Medicine Products: